Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ellis

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Mabs|February 14, 2023
TRYBE®: an Fc-free antibody format with three monovalent targeting arms engineered for long in vivo half-lifeEmma Davé, Oliver Durrant, Neha Dhami, et al.
Emerging Infectious Diseases|June 21, 2021
Pneumococcal Disease Outbreak at a State Prison, Alabama, USA, September 1-October 10, 2018<sup>1</sup>Guillermo V Sanchez, Constance L Bourne, Sherri L Davidson, et al.
Scientific Reports|March 16, 2016
Unlocking the genetic diversity of Creole wheatsPrashant Vikram, Jorge Franco, Juan Burgueño-Ferreira, et al.
Clinical and Vaccine Immunology : CVI|January 18, 2013
A mixture of functionally oligoclonal humanized monoclonal antibodies that neutralize Clostridium difficile TcdA and TcdB with high levels of in vitro potency shows in vivo protection in a hamster infection modelNicola L Davies, Joanne E Compson, Brendon Mackenzie, et al.
Science Translational Medicine|October 5, 2021
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal modelsBert Schepens, Loes van Schie, Wim Nerinckx, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Mabs|February 14, 2023
TRYBE®: an Fc-free antibody format with three monovalent targeting arms engineered for long in vivo half-lifeEmma Davé, Oliver Durrant, Neha Dhami, et al.
Emerging Infectious Diseases|June 21, 2021
Pneumococcal Disease Outbreak at a State Prison, Alabama, USA, September 1-October 10, 2018<sup>1</sup>Guillermo V Sanchez, Constance L Bourne, Sherri L Davidson, et al.
Scientific Reports|March 16, 2016
Unlocking the genetic diversity of Creole wheatsPrashant Vikram, Jorge Franco, Juan Burgueño-Ferreira, et al.
Clinical and Vaccine Immunology : CVI|January 18, 2013
A mixture of functionally oligoclonal humanized monoclonal antibodies that neutralize Clostridium difficile TcdA and TcdB with high levels of in vitro potency shows in vivo protection in a hamster infection modelNicola L Davies, Joanne E Compson, Brendon Mackenzie, et al.
Science Translational Medicine|October 5, 2021
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal modelsBert Schepens, Loes van Schie, Wim Nerinckx, et al.
Pageof 4